[Possibilities of combined and isolated application of carbapenems in patients with secondary widespread peritonitis].
The expediency of meronem (Ronem) application for empiric (beginning) therapy in patients, suffering secondary extended peritonitis were analized.
Pidhirnyĭ
Ia
Ia
Baryliak
R
R
Makovets'kyĭ
I
I
Shershen'
H
H
Pidhirna
M
M
D018806:APACHE; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D000077731:Meropenem; D010538:Peritonitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D011446:Prospective Studies; D012189:Retrospective Studies; D018746:Systemic Inflammatory Response Syndrome / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D013845:Thienamycins / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem